Harvard molecular pathologist, policy expert, and prolific author Dr Joe Lennerz has left his position at MGH Brigham to join BostonGene as its Chief Scientific Officer. See a recent open-access policy article from his group, here.
For more, see his postings on Linked In here:
https://www.linkedin.com/in/joe-lennerz-90029219/
Find the BostonGene website here:
https://bostongene.com/about-us/
BostonGene announced $150M in new funding eighteen months ago - here.
